ISIS-2
1988
Second International Study of Infarct Survival
In 17,187 patients with suspected acute myocardial infarction, aspirin plus intravenous streptokinase reduced 5-week vascular mortality compared with placebo.
Result
- Absolute difference
- 5.2 points
The absolute difference is derived from the event rates.
Also reported: Aspirin and streptokinase each independent.
- Subtopic
- Reperfusion
- Design
- 2×2 factorial RCT
- Relevance
- Practice-defining: a trial the guidelines cite as evidence.
- Cited in
- ESC 2023 ACSACC/AHA 2025 ACS
- Source
- ISIS-2 Collaborative Group. Lancet. 1988;332(8607):349-360.doi 10.1016/S0140-6736(88)92833-4
Discussion & critique
Predates primary PCI; defined the role of aspirin in MI and is the reason every chest-pain patient gets chewable aspirin. Streptokinase has been superseded by fibrin-specific lytics and primary PCI, but the aspirin signal still anchors modern ACS care.